References analysis of the Wikipedia article "NF-κB" in the Galician version

doi.org

dx.doi.org

Gilmore TD (2006). "Introduction to NF-κB: players, pathways, perspectives". Oncogene 25 (51): 6680–4. PMID 17072321. doi:10.1038/sj.onc.1209954.

Brasier AR (2006). "The NF-κB regulatory network". Cardiovasc. Toxicol. 6 (2): 111–30. PMID 17303919. doi:10.1385/CT:6:2:111.

Perkins ND (2007). "Integrating cell-signalling pathways with NF-κB and IKK function". Nat. Rev. Mol. Cell Biol. 8 (1): 49–62. PMID 17183360. doi:10.1038/nrm2083.

Gilmore TD (1999). "The Rel/NF-κB signal transduction pathway: introduction". Oncogene 18 (49): 6842–4. PMID 10602459. doi:10.1038/sj.onc.1203237.

Tian B, Brasier AR (2003). "Identification of a nuclear factor κ B-dependent gene network". Recent Prog. Horm. Res. 58: 95–130. PMID 12795416. doi:10.1210/rp.58.1.95.

Albensi BC, Mattson MP (2000). "Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity". Synapse 35 (2): 151–9. PMID 10611641. doi:10.1002/(SICI)1098-2396(200002)35:2<151::AID-SYN8>3.0.CO;2-P.

Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D (2003). "NF-kappa B functions in synaptic signaling and behavior". Nat. Neurosci. 6 (10): 1072–8. PMID 12947408. doi:10.1038/nn1110.

Levenson JM, Choi S, Lee SY, Cao YA, Ahn HJ, Worley KC, Pizzi M, Liou HC, Sweatt JD (2004). "A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel". J. Neurosci. 24 (16): 3933–43. PMID 15102909. doi:10.1523/JNEUROSCI.5646-03.2004.

Freudenthal R, Locatelli F, Hermitte G, Maldonado H, Lafourcade C, Delorenzi A, Romano A (1998). "Kappa-B like DNA-binding activity is enhanced after spaced training that induces long-term memory in the crab Chasmagnathus". Neurosci. Lett. 242 (3): 143–6. PMID 9530926. doi:10.1016/S0304-3940(98)00059-7.

Merlo E, Freudenthal R, Romano A (2002). "The IkappaB kinase inhibitor sulfasalazine impairs long-term memory in the crab Chasmagnathus". Neuroscience 112 (1): 161–72. PMID 12044481. doi:10.1016/S0306-4522(02)00049-0.

Sen R, Baltimore D (1986). "Multiple nuclear factors interact with the immunoglobulin enhancer sequences". Cell 46 (5): 705–16. PMID 3091258. doi:10.1016/0092-8674(86)90346-6.

Karin M, Ben-Neriah Y (2000). "Phosphorylation meets ubiquitination: the control of NF-κB activity". Annu. Rev. Immunol. 18: 621–63. PMID 10837071. doi:10.1146/annurev.immunol.18.1.621.

Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M (2001). "Activation by IKKalpha of a second, evolutionary conserved, NF-κB signaling pathway". Science 293 (5534): 1495–9. PMID 11520989. doi:10.1126/science.1062677.

Nabel GJ, Verma IM (1993). "Proposed NF-κB/IκB family nomenclature". Genes Dev. 7 (11): 2063. PMID 8224837. doi:10.1101/gad.7.11.2063.

Ghosh S, May MJ, Kopp EB (1998). "NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses". Annu. Rev. Immunol. 16: 225–60. PMID 9597130. doi:10.1146/annurev.immunol.16.1.225.

Waterhouse RM, Kriventseva EV, Meister S, Xi Z, Alvarez KS, Bartholomay LC, Barillas-Mury C, Bian G, Blandin S, Christensen BM, Dong Y, Jiang H, Kanost MR, Koutsos AC, Levashina EA, Li J, Ligoxygakis P, Maccallum RM, Mayhew GF, Mendes A, Michel K, Osta MA, Paskewitz S, Shin SW, Vlachou D, Wang L, Wei W, Zheng L, Zou Z, Severson DW, Raikhel AS, Kafatos FC, Dimopoulos G, Zdobnov EM, Christophides GK (2007). "Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes". Science 316 (5832): 1738–43. PMC 2042107. PMID 17588928. doi:10.1126/science.1139862.

Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, Ghosh G (2009). "NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes". EMBO Rep. 10 (2): 152–9. PMC 2637311. PMID 19098713. doi:10.1038/embor.2008.227.

(a) Chandel NS, Trzyna WC, McClintock DS, Schumacker PT (2000). "Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin". J Immunol 165 (2): 1013–1021. PMID 10878378.; (b) Fitzgerald DC, Meade KG, McEvoy AN, Lillis L, Murphy EP, MacHugh DE, Baird AW (2007). "Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells". Vet Immunol Immunopathol 116 (1-2): 59–68. PMID 17276517. doi:10.1016/j.vetimm.2006.12.008.; (c) Renard P, Zachary MD, Bougelet C, Mirault ME, Haegeman G, Remacle J, Raes M (1997). "Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation". Biochem Pharmacol 53 (2): 149–160. PMID 9037247.; (d) Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN (2005). "LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia". Blood 106 (9): 3114–3122. PMC 1895321. PMID 16020513. doi:10.1182/blood-2005-02-0759.; (e) Takemoto Y, Yoshiyama M, Takeuchi K, Omura T, Komatsu R, Izumi Y, Kim S, Yoshikawa J (1999). "Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling". J Mol Cell Cardiol 31 (11): 2017–2030. PMID 10591028. doi:10.1006/jmcc.1999.1033.; (f) Hargrave BY, Tiangco DA, Lattanzio FA, Beebe SJ (2003). "Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells". Cardiovasc Toxicol 3 (2): 141–151. PMID 14501032. doi:10.1385/CT:3:2:141.; (g) Basu S, Rosenzweig KR, Youmell M, Price BD (1998). "The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage". Biochem Biophys Res Commun 247 (1): 79–83. PMID 9636658. doi:10.1006/bbrc.1998.8741.

Baud'huin M, Lamoureux F, Duplomb L, Rédini F, Heymann D (2007). "RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases". Cell Mol Life Sci 64 (18): 2334–2350. PMID 17530461. doi:10.1007/s00018-007-7104-0.

Doyle SL, O'Neill LA (2006). "Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity". Biochem. Pharmacol. 72 (9): 1102–13. PMID 16930560. doi:10.1016/j.bcp.2006.07.010.

Hayden MS, West AP, Ghosh S (2006). "NF-κB and the immune response". Oncogene 25 (51): 6758–80. PMID 17072327. doi:10.1038/sj.onc.1209943.

Li Q, Verma IM (2002). "NF-κB regulation in the immune system". Nat. Rev. Immunol. 2 (10): 725–34. PMID 12360211. doi:10.1038/nri910.

Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D (1993). "The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers". Genes Dev. 7 (7B): 1354–63. PMID 8330739. doi:10.1101/gad.7.7b.1354.

Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U (1992). "The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition". Nature 359 (6393): 339–42. PMID 1406939. doi:10.1038/359339a0.

Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U (1993). "The oncoprotein Bcl-3 directly transactivates through κ B motifs via association with DNA-binding p50B homodimers". Cell 72 (5): 729–39. PMID 8453667. doi:10.1016/0092-8674(93)90401-B.

Jacobs MD, Harrison SC (1998). "Structure of an IκBalpha/NF-κB complex". Cell 95 (6): 749–58. PMID 9865693. doi:10.1016/S0092-8674(00)81698-0.

Basak S, Kim H, Kearns JD, Tergaonkar V, O'dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A (2007). "A fourth IκB protein within the NF-κB signaling module". Cell 128 (2): 369–81. PMC 1831796. PMID 17254973. doi:10.1016/j.cell.2006.12.033..

Lo JC, Basak S, James ES, Quiambo RS, Kinsella MC, Alegre ML, Weih F, Franzoso G, Hoffmann A, Fu YX (2006). "Coordination between NF-κB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues". Blood 107 (3): 1048–55. PMC 1895903. PMID 16195333. doi:10.1182/blood-2005-06-2452.

Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, White MR (2004). "Oscillations in NF-κB signaling control the dynamics of gene expression". Science 306 (5696): 704–8. PMID 15499023. doi:10.1126/science.1099962.

Hiscott J, Kwon H, Génin P (2001). "Hostile takeovers: viral appropriation of the NF-κB pathway". J. Clin. Invest. 107 (2): 143–51. PMC 199181. PMID 11160127. doi:10.1172/JCI11918.

Adkins I, Schulz S, Borgmann S, Autenrieth IB, Gröbner S (2008). "Differential roles of Yersinia outer protein P-mediated inhibition of nuclear factor-κB in the induction of cell death in dendritic cells and macrophages". J. Med. Microbiol. 57 (Pt 2): 139–44. PMID 18201977. doi:10.1099/jmm.0.47437-0.

Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, Tirone F (2005). "PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C". Mol. Cell. Biol. 25 (6): 2242–59. PMC 1061592. PMID 15743821. doi:10.1128/MCB.25.6.2242-2259.2005.

Micheli L, Leonardi L, Conti F, Maresca G, Colazingari S, Mattei E, Lira SA, Farioli-Vecchioli S, Caruso M, Tirone F (2011). "PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB". J. Biol. Chem. 286 (7): 5691–707. PMC 3037682. PMID 21127072. doi:10.1074/jbc.M110.162842.

Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M (2004). "Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers". EMBO J 23 (21): 4202–10. PMID 11547050. doi:10.1038/sj.emboj.7600391.

Basak S, Shih VF, Hoffmann A (2008). "Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system". Mol Cell Biol 28 (10): 3139–50. PMC 2423155. PMID 18299388. doi:10.1128/MCB.01469-07.

Livolsi A, Busuttil V, Imbert V, Abraham RT, Peyron JF (2001). "Tyrosine phosphorylation-dependent activation of NF-κB. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases". Eur. J. Biochem. 268 (5): 1508–15. PMID 11231305. doi:10.1046/j.1432-1327.2001.02028.x.

Heckscher ES, Fetter RD, Marek KW, Albin SD, Davis GW (2007). "NF-kappaB, IkappaB, and IRAK control glutamate receptor density at the Drosophila NMJ". Neuron 55 (6): 859–73. PMC 2701504. PMID 17880891. doi:10.1016/j.neuron.2007.08.005.

Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prüllage M, Pfeiffer J, Lindecke A, Staiger V, Israël A, Kaltschmidt C, Mémet S (2006). "NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling". Mol. Cell. Biol. 26 (8): 2936–46. PMC 1446931. PMID 16581769. doi:10.1128/MCB.26.8.2936-2946.2006.

Wang J, Fu XQ, Lei WL, Wang T, Sheng AL, Luo ZG (2010). "Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction". J. Neurosci. 30 (33): 11104–13. PMID 20720118. doi:10.1523/JNEUROSCI.2118-10.2010.

Boersma MC, Dresselhaus EC, De Biase LM, Mihalas AB, Bergles DE, Meffert MK (2011). "A Requirement for Nuclear Factor-κB in Developmental and Plasticity-Associated Synaptogenesis". J. Neurosci. 31 (14): 5414–25. PMID 21471377. doi:10.1523/JNEUROSCI.2456-10.2011.

Gutierrez H, Hale VA, Dolcet X, Davies A (2005). "NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS". Development 132 (7): 1713–26. PMID 15743881. doi:10.1242/dev.01702.

Borges K, Dingledine R (2001). "Functional organization of the GluR1 glutamate receptor promoter". J. Biol. Chem. 276 (28): 25929–38. PMID 11340067. doi:10.1074/jbc.M009105200.

Yu Z, Cheng G, Wen X, Wu GD, Lee WT, Pleasure D (2002). "Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaB-dependent mechanism". Neurobiol. Dis. 11 (1): 199–213. PMID 12460558. doi:10.1006/nbdi.2002.0530.

Richter M, Suau P, Ponte I (2002). "Sequence and analysis of the 5' flanking and 5' untranslated regions of the rat N-methyl-D-aspartate receptor 2A gene". Gene 295 (1): 135–42. PMID 12242020. doi:10.1016/S0378-1119(02)00833-8.

Begni S, Moraschi S, Bignotti S, Fumagalli F, Rillosi L, Perez J, Gennarelli M (2003). "Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia". Biol. Psychiatry 53 (7): 617–9. PMID 12679240. doi:10.1016/S0006-3223(02)01783-3.

Zaheer A, Yorek MA, Lim R (2001). "Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion". Neurochem. Res. 26 (12): 1293–9. PMID 11885780. doi:10.1023/A:1014241300179.

Qiu J, Hu X, Nesic O, Grafe MR, Rassin DK, Wood TG, Perez-Polo JR (2004). "Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia". J. Neurosci. Res. 77 (1): 108–18. PMID 15197744. doi:10.1002/jnr.20156.

Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A (2007). "The transcription factor nuclear factor-κB and cancer". Clinical Oncology (Royal College of Radiologists (Great Britain)) 19 (2): 154–61. PMID 17355113. doi:10.1016/j.clon.2006.11.013.

Venuraju SM, Yerramasu A, Corder R, Lahiri A (2010). "Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity". J. Am. Coll. Cardiol. 55 (19): 2049–61. PMID 20447527. doi:10.1016/j.jacc.2010.03.013.

Lieb W, Gona P, Larson MG, Massaro JM, Lipinska I, Keaney JF, Rong J, Corey D, Hoffmann U, Fox CS, Vasan RS, Benjamin EJ, O'Donnell CJ, Kathiresan S (2010). "Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality". Arterioscler. Thromb. Vasc. Biol. 30 (9): 1849–54. PMC 3039214. PMID 20448212. doi:10.1161/ATVBAHA.109.199661.

Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP (2009). "The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia". Biol. Psychiatry 65 (6): 481–8. PMID 19058794. doi:10.1016/j.biopsych.2008.10.018.

Karin M (2008). "The IκB kinase - a bridge between inflammation and cancer". Cell Res. 18 (3): 334–42. PMID 18301380. doi:10.1038/cr.2008.30.

Pikarsky E, Ben-Neriah Y (2006). "NF-κB inhibition: a double-edged sword in cancer?". Eur. J. Cancer 42 (6): 779–84. PMID 16530406. doi:10.1016/j.ejca.2006.01.011.

Mantovani A, Marchesi F, Portal C, Allavena P, Sica A (2008). "Linking inflammation reactions to cancer: novel targets for therapeutic strategies". Adv. Exp. Med. Biol. 610: 112–27. PMID 18593019. doi:10.1007/978-0-387-73898-7_9.

Paur I, Balstad TR, Kolberg M, Pedersen MK, Austenaa LM, Jacobs DR, Blomhoff R (2010). "Extract of oregano, coffee, thyme, clove, and walnuts inhibits NF-kappaB in monocytes and in transgenic reporter mice". Cancer Prev Res (Phila) 3 (5): 653–63. PMID 20424131. doi:10.1158/1940-6207.CAPR-09-0089.

Garg A, Aggarwal BB (2002). "Nuclear transcription factor-kappaB as a target for cancer drug development". Leukemia 16 (6): 1053–68. PMID 12040437. doi:10.1038/sj.leu.2402482.

Sethi G, Sung B, Aggarwal BB (2008). "Nuclear factor-kappaB activation: from bench to bedside". Exp. Biol. Med. (Maywood) 233 (1): 21–31. PMID 18156302. doi:10.3181/0707-MR-196.

Hamdy NA (2008). "Denosumab: RANKL inhibition in the management of bone loss". Drugs Today (Barc). 44 (1): 7–21. PMID 18301800. doi:10.1358/dot.2008.44.1.1178467.

Cvek B, Dvorak Z (2007). "Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals". Curr. Pharm. Des. 13 (30): 3155–67. PMID 17979756. doi:10.2174/138161207782110390.

espacenet.com

worldwide.espacenet.com

US patent 6410516, Baltimore D; Sen R; Sharp PA; Singh H; Staudt L; Lebowitz JH; Baldwin Jr AS; Clerc RG; Corcoran LM; Baeuerle PA; Lenardo MJ; Fan C-M; Maniatis TPD, "Nuclear factors associated with transcriptional regulation", issued 2002-06-25. US patent reference | number = 6410516 | y = 2002 | m = 06 | d = 25 [1]

nih.gov

ncbi.nlm.nih.gov